These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20514097)

  • 1. [Use of bisphosphonates in chronic kidney disease].
    Torregrosa JV; Ramos AM
    Nefrologia; 2010; 30(3):288-96. PubMed ID: 20514097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphophonates in CKD patients with low bone mineral density.
    Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
    ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
    Toussaint ND; Elder GJ; Kerr PG
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term use of bisphosphonates in osteoporosis.
    Watts NB; Diab DL
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
    Persy V; De Broe M; Ketteler M
    Kidney Int; 2006 Nov; 70(9):1537-8. PubMed ID: 17051257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.
    Miller PD
    Curr Osteoporos Rep; 2005 Mar; 3(1):5-12. PubMed ID: 16036095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates and oral pathology I. General and preventive aspects.
    Ponte Fernández N; Estefania Fresco R; Aguirre Urizar JM
    Med Oral Patol Oral Cir Bucal; 2006 Aug; 11(5):E396-400. PubMed ID: 16878067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
    Cremers S; Farooki A
    Ann N Y Acad Sci; 2011 Feb; 1218():80-7. PubMed ID: 20946577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues.
    Rodd C
    Perit Dial Int; 2001; 21 Suppl 3():S256-60. PubMed ID: 11887832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder].
    Mori H; Okada Y; Tanaka Y; Hashimoto O
    Clin Calcium; 2012 Jul; 22(7):1034-42. PubMed ID: 22750936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and osteonecrosis of the jaw.
    Shenker NG; Jawad AS
    Rheumatology (Oxford); 2007 Jul; 46(7):1049-51. PubMed ID: 17500074
    [No Abstract]   [Full Text] [Related]  

  • 15. Alveolar bone and the bisphosphonates.
    Cheng A; Daly CG; Logan RM; Stein B; Goss AN
    Aust Dent J; 2009 Sep; 54 Suppl 1():S51-61. PubMed ID: 19737268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety profile of intravenous bisphosphonates.
    Mehrotra B
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S24-7. PubMed ID: 18068487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for bisphosphonates in chronic kidney disease?
    Miller PD
    Semin Dial; 2007; 20(3):186-90. PubMed ID: 17555478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
    Lewis DM
    J Okla Dent Assoc; 2011; 102(5):36-9. PubMed ID: 21874699
    [No Abstract]   [Full Text] [Related]  

  • 20. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
    Lee J
    J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.